Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
22.23 x 4 22.26 x 2
Post-market by (Cboe BZX)
22.14 +0.10 (+0.45%) 04/17/25 [NYSE]
22.23 x 4 22.26 x 2
Post-market 22.25 +0.11 (+0.50%) 19:59 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
22.10
Day High
22.55
Open 22.15
Previous Close 22.04 22.04
Volume 54,073,600 54,073,600
Avg Vol 72,006,414 72,006,414
Stochastic %K 28.64% 28.64%
Weighted Alpha -22.27 -22.27
5-Day Change +0.55 (+2.55%) +0.55 (+2.55%)
52-Week Range 20.92 - 31.54 20.92 - 31.54
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 125,566,008
  • Shares Outstanding, K 5,671,455
  • Annual Sales, $ 63,627 M
  • Annual Income, $ 8,031 M
  • EBIT $ 17,697 M
  • EBITDA $ 24,710 M
  • 60-Month Beta 0.67
  • Price/Sales 1.96
  • Price/Cash Flow 5.05
  • Price/Book 1.41

Options Overview Details

View History
  • Implied Volatility 33.00% ( -3.42%)
  • Historical Volatility 29.85%
  • IV Percentile 96%
  • IV Rank 43.64%
  • IV High 52.17% on 04/10/25
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.63
  • Today's Volume 119,956
  • Volume Avg (30-Day) 195,394
  • Put/Call OI Ratio 0.93
  • Today's Open Interest 3,511,821
  • Open Int (30-Day) 3,189,538

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.67
  • Number of Estimates 6
  • High Estimate 0.81
  • Low Estimate 0.60
  • Prior Year 0.82
  • Growth Rate Est. (year over year) -18.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.92 +5.86%
on 04/09/25
Period Open: 26.05
26.52 -16.52%
on 03/21/25
-3.91 (-15.01%)
since 03/17/25
3-Month
20.92 +5.86%
on 04/09/25
Period Open: 26.30
27.24 -18.72%
on 03/10/25
-4.16 (-15.82%)
since 01/17/25
52-Week
20.92 +5.86%
on 04/09/25
Period Open: 25.42
31.54 -29.80%
on 07/30/24
-3.28 (-12.90%)
since 04/17/24

Most Recent Stories

More News
3 Ultra-High-Yield Dividend Stocks to Buy Right Now That Are Dirt Cheap

Every cloud has a silver lining. Sometimes, they have two. That's the case with many stocks in the current market downturn. Dividend yields are higher. Valuations are lower. And those are two big pluses...

EPD : 31.02 (+1.91%)
PFE : 22.14 (+0.45%)
ARCC : 20.40 (+1.54%)
A Once-in-a-Decade Opportunity: 3 Magnificent Stocks Down Between 40% and 73% to Buy Right Now

The S&P 500 has dropped 10% or more nine times since 2010, not including the current sell-off. However, the index has delivered an average return of 18% in the year following the start date of these corrections...

WING : 218.84 (+0.46%)
ZTS : 148.67 (+1.30%)
YETI : 27.86 (+3.41%)
PFE : 22.14 (+0.45%)
3 Magnificent Stocks to Buy That Are Near 52-Week Lows

It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump administration....

ZTS : 148.67 (+1.30%)
NKE : 55.76 (+4.13%)
PFE : 22.14 (+0.45%)
Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?

Although it isn't the largest therapeutic area in the pharmaceutical industry, the market for weight loss therapies has caught fire in recent years. The leading medicines in this field include household...

PFE : 22.14 (+0.45%)
Where Will Eli Lilly Be in 5 Years?

What a difference five years can make. Just look at Eli Lilly (NYSE: LLY) . In April 2020, the drugmaker stood in the shadows to some extent with companies including Johnson & Johnson, Pfizer , and Merck...

NVO : 58.08 (-7.63%)
MRK : 78.00 (+2.01%)
JNJ : 157.47 (+2.31%)
LLY : 839.96 (+14.30%)
PFE : 22.14 (+0.45%)
3 Magnificent S&P 500 Dividend Stocks Down 11% to 63% to Buy and Hold Forever

As tough as it may be to do right now, this is a great time to hold your nose and dive in while yields are as high as they are.

CSCO : 55.76 (unch)
PEP : 142.84 (+1.96%)
PFE : 22.14 (+0.45%)
This Dividend Stock Yields Nearly 8% and Trades at Depressed Valuations: Time to Buy?

Amid the continued decline in Pfizer stock, its dividend yield has risen to almost 8%. While the stock might not be a screaming buy, it now seems to have limited downside.

$SPX : 5,282.70 (unch)
PFE : 22.14 (+0.45%)
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Eli Lilly has a plan to dominate the GLP-1 weight loss drug market -- and it's succeeding.

VKTX : 23.94 (+1.44%)
NVO : 58.08 (-7.63%)
HIMS : 27.23 (+1.04%)
LLY : 839.96 (+14.30%)
PFE : 22.14 (+0.45%)
Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback

J&J JNJ began the earnings season for the drug and biotech sector this week. Pfizer PFE announced the discontinuation of its danuglipron weight loss pill program. The European Commission granted marketing...

JNJ : 157.47 (+2.31%)
RHHBY : 38.9000 (+0.83%)
PFE : 22.14 (+0.45%)
SNY : 50.90 (+0.67%)
Trump Tariff Plunge: 3 Phenomenal Stocks to Buy at Bargain Prices Right Now

Tariff uncertainty has created an ideal opportunity for long-term investors to pounce.

COMP : 7.29 (-3.95%)
$NASX : 16,286.45 (-0.13%)
AZO : 3,603.47 (+1.03%)
$SPX : 5,282.70 (unch)
EPD : 31.02 (+1.91%)
$DOWI : 39,142.23 (-1.33%)
PFE : 22.14 (+0.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 22.88
2nd Resistance Point 22.71
1st Resistance Point 22.43
Last Price 22.14
1st Support Level 21.98
2nd Support Level 21.81
3rd Support Level 21.53

See More

52-Week High 31.54
Fibonacci 61.8% 27.48
Fibonacci 50% 26.23
Fibonacci 38.2% 24.97
Last Price 22.14
52-Week Low 20.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro